About
Care and conscience are
the core of our corporate values
more
the core of our corporate values
04 Jan,2021
SWEDEPAD Interim Analysis Shows No Mortality Difference Found for Paclitaxel-Coated Devices.
On December 9, 2020, the New England Journal of Medicine published an article based on the findings from the Swedish Drug Elution Trial in Peripheral Arterial Disease (SWEDEPAD). The SWEDEPAD trial is...
more
28 Dec,2020
TonBridge Medical obtained the certificate of intellectual property management system certification
In December 2020, with the efforts of the General Manager Office and various departments, Zhuhai TonBridge Medical Technology Co., Ltd. successfully completed the "GB/T29490-2013 Enterprise Intel...
more
14 Dec,2020
TonBridge Medical won the Science and Technology Innovation Leader of 2020 and Science and Technology Innovation Product of 2020
Zhuhai TonBridge Medical Technology Co., Ltd. won two important awards in the selection of outstanding scientific and technological innovation workers and scientific and technological innovation achie...
more
08 Dec,2020
Zylox Medical's Staff ran the 2020 Hangzhou Dream Town Half Marathon
2020 Hangzhou Dream Town Half Marathon kicked off on Nov 29. 30 employees of Zylox medical signed up and completed the race. This is the second time that Zylox Medical's staff take part in this ev...
more
23 Nov,2020
Zylox Medical's ZENFluxion™ and ZENFLEX Pro™ Received CE Certificate
Zylox Medical announced that its ZENFluxion™ Drug Coated PTA Balloon Catheter and ZENFLEX Pro™ Peripheral Drug eluting Stent System have received CE Certificate on October 28 (2020).ZENFluxion™ DCB...
more
23 Nov,2020
TonBridge Medical won two Bronze Award of
In November 2020, at the 24th National Invention Exhibition, Zhuhai TonBridge Medical Technology Co., Ltd. won two important awards. The two projects "ThromBite™ Clot Retriever Device" and ...
more
